Invitae Corporation, a medical genetics company, integrates genetic information into healthcare decision-making by clinicians and patients in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and rare diseases. It serves patients, healthcare providers, biopharma companies, and other partners. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was founded in 2010 and is headquartered in San Francisco, California.
IPO Year: 2015
Exchange: NYSE
Website: invitae.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 7/5/2023 | Underweight | JP Morgan | |
| 5/15/2023 | Mkt Perform → Underperform | Raymond James | |
| 1/31/2023 | $2.00 | Neutral → Sell | Goldman |
| 8/25/2022 | $1.00 | Underperform | Credit Suisse |
| 8/10/2022 | Neutral → Underweight | JP Morgan | |
| 7/26/2022 | $8.00 → $2.50 | Outperform → Market Perform | Cowen |
| 7/21/2022 | Outperform → Mkt Perform | Raymond James | |
| 7/20/2022 | Buy → Neutral | Ladenburg Thalmann | |
| 7/19/2022 | Buy → Hold | The Benchmark Company | |
| 7/19/2022 | Outperform → Mkt Perform | SVB Leerink |
JP Morgan resumed coverage of Invitae with a rating of Underweight
Raymond James downgraded Invitae from Mkt Perform to Underperform
Goldman downgraded Invitae from Neutral to Sell and set a new price target of $2.00
Credit Suisse initiated coverage of Invitae with a rating of Underperform and set a new price target of $1.00
JP Morgan downgraded Invitae from Neutral to Underweight
Cowen downgraded Invitae from Outperform to Market Perform and set a new price target of $2.50 from $8.00 previously
Raymond James downgraded Invitae from Outperform to Mkt Perform
Ladenburg Thalmann downgraded Invitae from Buy to Neutral
The Benchmark Company downgraded Invitae from Buy to Hold
SVB Leerink downgraded Invitae from Outperform to Mkt Perform
4 - Invitae Corp (0001501134) (Issuer)
4 - Invitae Corp (0001501134) (Issuer)
4 - Invitae Corp (0001501134) (Issuer)
3 - Invitae Corp (0001501134) (Issuer)
4 - Invitae Corp (0001501134) (Issuer)
4 - Invitae Corp (0001501134) (Issuer)
3 - Invitae Corp (0001501134) (Issuer)
4 - Invitae Corp (0001501134) (Issuer)
3 - Invitae Corp (0001501134) (Issuer)
3 - Invitae Corp (0001501134) (Issuer)